The European Vision Institute (EVI) is pleased to present the 2012 edition of the calendar to share the beauty and grace of this exciting field of biomedicine and life science.
The photo motifs of the calendar are the results from the 2011 picture competition that had been posted on this web-portal where you can find up-to-date information on developments in Vision Research and Ophthalmology, covering all aspects of basic and translational research in the private and public sector.
This calendar should raise awareness for Vision Research and Ophthalmology and to support the major aims of EVI as an
The European Vision Institute, a non-profit organization aims at devising and implementing programs and research projects for new strategies for eye diseases that are difficult or impossible to be treated presently, as blindness is one of the most feared health hazards in our present society and millions of Europeans are threatened by eye diseases producing costs of several billion Euros per year.
Since its foundation in 1890, Santen Pharmaceutical Co., Ltd. has contributed to the protection and improvement of people's eyesight and health. Santen's integrated operations extend from research and development to production and sales of prescription and over-the-counter pharmaceuticals.
Today, Santen specializes in original ophthalmic and anti-rheumatic pharmaceuticals as it works to create superior pharmaceuticals for all types of ophthalmic disorders and offer information that meets clinical needs. As a result, Santen leads Japan's market for prescription ophthalmics, which represent over 80 percent of Company sales.
With marketing and development bases in Japan, the United States and Europe, backed by first-rate R&D capabilities, Santen aims to increase corporate value to become a world-class company that delivers unique products to patients worldwide.